B. AYGEN Et Al. , "Ombitasvir/paritoprevir/ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Turkey," APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver , 2018
AYGEN, B. Et Al. 2018. Ombitasvir/paritoprevir/ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Turkey. APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver .
AYGEN, B., YILDIZ, O., GÖKAHMETOĞLU, S., & TOKGÖZ, B., (2018). Ombitasvir/paritoprevir/ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Turkey . APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver
AYGEN, BİLGEHAN Et Al. "Ombitasvir/paritoprevir/ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Turkey," APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver, 2018
AYGEN, BİLGEHAN Et Al. "Ombitasvir/paritoprevir/ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Turkey." APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver , 2018
AYGEN, B. Et Al. (2018) . "Ombitasvir/paritoprevir/ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Turkey." APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver .
@conferencepaper{conferencepaper, author={BİLGEHAN AYGEN Et Al. }, title={Ombitasvir/paritoprevir/ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Turkey}, congress name={APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver}, city={}, country={}, year={2018}}